Sleep Effectiveness and Insulin and Glucose Homeostasis

Trial Profile

Sleep Effectiveness and Insulin and Glucose Homeostasis

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Prediabetic-state; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
    • 17 Dec 2015 Status changed from recruiting to active, no longer recruiting according to ClinicalTrials.gov record.
    • 17 Dec 2015 Planned End Date changed from 1 Aug 2014 to 1 Dec 2016 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top